Choline kinases: Enzymatic activity, involvement in cancer and other diseases, inhibitors

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Tumor metabolism differs from healthy tissue, notably through choline phosphorylation by choline kinases (CHKα and CHKβ).
• Phosphatidylcholine synthesis is initiated by this process, impacting cancer cell behavior.
• A gap exists in comprehensive reviews on CHK's role in cancer and the anti-tumor potential of its inhibitors.

Purpose of the Study:

• To review the enzymatic and non-enzymatic properties of CHKα and CHKβ.
• To elucidate their involvement in cancer processes, especially proliferation.
• To discuss clinical aspects and the therapeutic potential of CHKα inhibitors.

Main Methods:

• Literature review of enzymatic and non-enzymatic properties of CHKα and CHKβ.
• Analysis of CHK's role in cancer cell proliferation.
• Examination of clinical data across multiple cancer types.
• Evaluation of CHKα inhibitors as potential anti-cancer agents.

Main Results:

• CHKα and CHKβ are integral to cancer processes, particularly proliferation.
• Choline kinases are implicated in various cancers, including pancreatic, ovarian, lung, breast, and hematological malignancies.
• CHKα inhibitors show promise as anti-tumor therapeutics, though not yet in clinical trials.

Conclusions:

• Understanding CHKα and CHKβ functions is crucial for cancer research.
• CHKα inhibitors represent a potential new avenue for cancer treatment.
• Choline kinases also have implications in non-cancerous diseases.